paperBiotech

Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies

Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies

publishedDate Venue Life Sciences

Source-permitted summary

Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies

SourceElsevier BV

Verified by AISci

Public source attached

Source status for this paper in the current AISci reviewed snapshot.

Primary source
Elsevier BV
Correction status
none
Evidence coverage
1 sources / 1 publishers
Last metadata check
Jul 19, 2026
Open primary source

AI Reading Notes

Core signal

Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.

Core signal
Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies
Field context
Genomics and Gene Editing
People and labs
Not stated in the reviewed source.
Why it matters
Recent source-backed research output for AISci Stage A browsing.
Limits to check
AISci rank score does not assess scientific quality or citation impact.

Publication facts

Date
Jul 1, 2026SourceElsevier BV
Venue
Life SciencesSourceElsevier BV
Open access
unknownSourceElsevier BV

External IDs

Author order

No reviewed author edge is attached to this output.

Organizations

No source-confirmed author affiliation is attached.

Related events

Topics

Relationship evidence

Timeline

  1. paperNext-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies